About the Authors
- Rob N. de Jong
-
Contributed equally to this work with: Rob N. de Jong, Frank J. Beurskens
Affiliation Genmab, Utrecht, The Netherlands
- Frank J. Beurskens
-
Contributed equally to this work with: Rob N. de Jong, Frank J. Beurskens
Affiliation Genmab, Utrecht, The Netherlands
- Sandra Verploegen
-
Affiliation Genmab, Utrecht, The Netherlands
- Kristin Strumane
-
Affiliation Genmab, Utrecht, The Netherlands
- Muriel D. van Kampen
-
Affiliation Genmab, Utrecht, The Netherlands
- Marleen Voorhorst
-
Affiliation Genmab, Utrecht, The Netherlands
- Wendy Horstman
-
Affiliation Genmab, Utrecht, The Netherlands
- Patrick J. Engelberts
-
Affiliation Genmab, Utrecht, The Netherlands
- Simone C. Oostindie
-
Affiliation Genmab, Utrecht, The Netherlands
- Guanbo Wang
-
Affiliations Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands, Netherlands Proteomics Centre, Utrecht, The Netherlands
- Albert J. R. Heck
-
Affiliations Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands, Netherlands Proteomics Centre, Utrecht, The Netherlands
- Janine Schuurman
-
Affiliation Genmab, Utrecht, The Netherlands
- Paul W. H. I. Parren
-
* E-mail: p.parren@genmab.com
Affiliations Genmab, Utrecht, The Netherlands, Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark, Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands
Competing Interests
I have read the journal's policy and the authors of this manuscript have the following competing interests: RNdJ, FJB, SV, KS, MV, WH, PJE, SCO, MDvK, JS and PWHIP are Genmab employees and own Genmab warrants and/or stock. RNdJ, FJB, JS and PWHIP are inventors on Genmab patent applications. In this manuscript we described the identification of a new antibody platform for the development of therapeutic antibodies, which we have registered under the trade name “HexaBody.”
Author Contributions
Conceived and designed the experiments: RNdJ FJB SV MDvK GW AJRH JS PWHIP. Performed the experiments: RNdJ MV WH PJE SCO GW. Analyzed the data: RNdJ FJB SV MDvK MV WH PJE SCO GW AJRH JS PWHIP. Wrote the paper: RNdJ FJB SV KS AJRH JS PWHIP.